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Abstract The effects of insulin and IGF-I on the cell surface 
quantities of GLUT1, GLUT3 and GLUT4 glucose transporters 
in L6 myotubes were determined with the exofacial bis-mannose 
phololabel (ATB-BMPA). In basal cells, an equal molar quantity 
of each transporter isoform was found at the ceil surface. Insulin 
stimulated the translocation of all three glucose transporter 
isoforms to the plasma membrane fraction from the light micro- 
some fraction, resulting in equal molar quantities on the cell 
surface. IGF-I stimulated a similar translocation of all isoforms, 
augmented by an increase in surface GLUT3 as assessed by 
ATB-BMPA. 
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1. Introduction 
The L6 cell line has been used to investigate skeletal muscle 
glucose uptake inresponse to acute stimulation by insulin or 
IGF-I .  L6 differentiated myotubes were found to contain mul- 
tiple glucose transporter isoforms [1,2]. These include GLUT1 
which is ubiquitously expressed, GLUT3 which is expressed 
principally in neurons of rodents, and GLUT4 which is ex- 
pressed in insulin responsive tissues (see reviews [3-5]). Subcel- 
lular fractionation demonstrated that GLUT1,  GLUT3 and 
GLUT4 protein levels increase in the plasma membrane-en- 
riched fraction in response to insulin or IGF- I  treatment. Acute 
stimulation with either hormone did not alter mRNA of 
GLUT I  or GLUT4,  nor total protein levels of GLUT1,  
GLUT3,  or GLUT4 [1,2,6,7]. Therefore, the increase in glucose 
uptake could not be accounted for by hormonal stimulation of 
glucose transporter protein synthesis but, instead appeared to 
correspond to a redistribution of transporters. However, due 
to the differences in antibody immunoreactivity and limitations 
of membrane fractionation, these techniques cannot be used to 
make comparisons between the molar ratios of each isoform 
nor the quantities of functional transporters on the cell surface 
in control and hormonally stimulated cells. 
The impermeant exofacial photoaffinity label 2-N-4-[3H](1 - 
azi-2,2,2-trifluoroethyl)benzoyl-l,3-bis-(D-mannose-4-yloxyl)- 
2-propylamine (ATB-BMPA) has been used to quantitate the 
functional cell surface levels of GLUT 1, GLUT2,  GLUT3,  and 
GLUT4 in intact tissues and in cell cultures [8 13]. The aim of 
this study was to quantitate the functional cell surface levels of 
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each glucose transporter isoform present in the L6 myotubes 
in response to insulin and IGF-I .  
2. Materials and methods 
2.1. Materials 
s-Minimal Essential Medium (~-MEM), fetal bovine serum, and 
other tissue culture reagents were obtained from Gibco (Burlington, 
Ont.). Human recombinant IGF-I was a gift from Dr. M. Vranic, 
University of Toronto, Toronto, Canada. Insulin, cytochalasin B, and 
2-deoxyglucose w re obtained from Sigma (St. Louis, MO). 2-Deoxy- 
[3H]D-glucose was purchased from ICN (Irvine, CA). Protein-A-Sepha- 
rose CL-4B (PAS) was obtained from Pharmacia (Piscataway, NJ). 
Rabbit polyclonal antisera, specific for the COOH-terminal sequences 
of GLUTI (amino acids 472~92), mouse-GLUT3 (amino acids 474~ 
493), and GLUT4 (amino acids 490-509) were kindly supplied by 
Hoffmann-La Roche (Nutley, N J). The ATB-BMPA, specific activity 
of 10 Ci/mmol, was a kind gift from Dr. G.D. Holman, University of 
Bath, Bath, UK. 
2.2. Cell culture 
A spontaneously rapid fusing subclone of the original L6 skeletal 
muscle cell line [14] was grown in monolayer to the stage of 90% fused 
myotubes as previously described [2]. Cells were deprived of serum for 
5 h prior to experimentation using serum free cc-MEM supplemented 
to 25 mM glucose (final concentration). For hormonal stimulation, the 
medium was replaced with fresh serum-free ~-MEM supplemented to 
25 mM glucose with or without insulin (100 nM) or IGF-I (10 nM) at 
37°C for 30 min prior to the assays. 
2.3. 2-Deoxy-FH]D-glucose uptake 
After the hormone treatment, cell monolayers were rinsed with glu- 
cose-free HEPES buffered saline (HBS) and glucose uptake was meas- 
ured in HBS with or without hormone, as previously described using 
10/IM 2-deoxy-[3H]D-glucose (1/ICi/ml) for 10 min [6]. The results of 
specific uptake are expressed as pmol/mg total cell protein/min. Total 
cell protein/dish was determined by the Bradford method [15]. 
2.4. Photolabeling 
As for the transport assay, after hormonal treatment, he cells were 
washed three times in HBS solution. ATB-BMPA was added to 
1 mCi/ml (100/IM) in 1 ml HBS with or without hormone for 1 min. 
Cells were then irradiated for 2 × 1 min intervals using a Rayonet 
photochemical reactor (with 300 nM lamps) with gentle rocking be- 
tween exposures to keep the monolayer moistened. The radioactive 
medium was aspirated and the cells were immediately solubilized in 1 
ml of 2% Thesit (C30H62Oi0) detergent (Boehringer-Mannheim, Indian- 
apolis, IN) for 30 min at room temperature aspreviously described [9]. 
The solubilized cells were scraped off the dish and centrifuged at14,000 
rpm for 10 min to remove insoluble debris. Two 10 ml samples were 
retained for duplicate protein determination using the bicinchoninic 
acid assay (Pierce Rockford, IL). 
2.5. Immunoprecipitation a d quan titation of A TB-BMPA-labeled 
glucose transporters 
Immunoprecipitation was carried out as previously described [12,13] 
with the following modifications. Thesit-solubilized total L6 protein 
was first added to 80 pl of uncoupled 50% PAS (as a preclearing step 
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to remove non-specific binding) for 20 min at 4°C. The precleared 
samples were then transferred to the antibody/PAS immunocomplex 
and mixed at 4°C for 4 h (for each immunoprecipitation) in the sequen- 
tial order of GLUT4, GLUT3 then GLUT1. The GLUT3 and GLUT1 
immunoprecipitations were carried out twice to maximize fficiency. 
These procedures gave an efficiency of 85-90% for each isoform. After 
precipitation, the pellet was washed twice with 1 ml of 0.2% Thesit in 
PBS followed by 2 × 1 ml PBS. Finally, the immunoprecipitates were 
eluted from the PAS with sample buffer containing 15 mM Tris, 1.5% 
SDS, 2.3 M urea, and 100 mM dithiothreitol (final concentrations) for 
30 min at room temperature. Solubilized immunoprecipitates were re- 
covered by centrifugation through Millipore 0.45/tm filters inmicro- 
fuge tubes and loaded on 10% SDS-polyacrylamide gels for electropho- 
resis. In the cases where 2 rounds of immunoprecipitation were per- 
formed, the solubilized complexes were pooled prior to loading on the 
gels. The gels were cut, solubilized and counted for 3H as previously 
described [10,13]. The peak corresponding to each transporter was 
quantitated and expressed as dpm/mg protein for each dish. 
2.6. Calculations 
A value for total cell surface binding, B ..... was derived by the equa- 
tion Bma x = (B)(gd)((1 +F/ga)/b-) with dissociation constants, Kj, previ- 
ously determined for ATB-BMPA binding to each transporter isoform 
(GLUT1 = 150 /.tM, GLUT4-- 150 /lM, GLUT3 = 55 /IM) 
[10,12,16,17], the concentration of free ligand (F= 100/IM), and the 
measured bound ligand (B) in pmol/mg total protein, (calculated from 
the specific activity and total cell surface binding) [17,18]. This calcula- 
tion accounts for the affinity differences of each glucose transporter 
isoform for ATB-BMPA. All data are reported as the final (corrected) 
molar concentrations (pmol/mg total protein), and comparisons were 
made using these values. 
Statistical significance was tested with a one-way analysis of variance 
followed by a Student-Newman-Keuls or Fisher PLSD post-hoc analy- 
sis, where differences were accepted as significant at the P < 0.05 level. 
2. 7. Membrane isolation and Western blotting 
L6 myotubes were grown and stimulated with insulin and IGF-I as 
described above to use for membrane fractionation. Plasma membrane 
fractions and intracellular light microsome fractions were prepared, 
equivalent amounts of protein for each membrane fraction were loaded 
on SDS-polyacrylamide gels and Western blotted using the C-terminus 
specific antisera, as previously reported [1,6]. Values are reported as 
relative densitometric units per mg protein. 
3. Results 
3.1. 2-Deoxy-FH]D-glucose uptake 
Fig. 1 shows the 2-deoxyglucose uptake (pmol/mg protein/ 
min) in unstimulated (basal) cells and after 30 min of insulin- 
or IGF-I-treatment. Insulin-stimulated uptake was 160% 
greater than basal (P<0.05) and IGF-I  stimulated uptake was 
210% greater than basal (P<0.01). 
3.2. Cell surface glucose transporters 
The cell surface quantities of all three glucose transporter 
isoforms were determined by photolabeling with the imper- 
meant ATB-BMPA. The specificity of ATB-BMPA was first 
tested by photoaffinity labeling in the presence or absence of 
cytochalasin B. The peak of radioactivity for each glucose 
transporter isoform was reduced by 90% by cytochalasin B
(data not shown). 
The proportions of cell surface GLUT I ,  GLUT3 and 
GLUT4 in basal, insulin and IGF-I  treated myotubes are 
shown in Fig. 2. In basal myotubes there were no statistical 
differences between the functional quantities of the glucose 
transporter isoforms at the cell surface (GLUT1 = 1.42 + 0.20, 
GLUT3 = 0.98 + 0.36, and GLUT4 = 1.16 + 0.24 x 10 _2 pmol/ 
mg). 
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Fig. 1.2-Deoxy-[3H]D-glucose uptake in L6 myotubes, inbasal, 100 nM 
insulin- and 10 nM IGF-I-treated cells. Hexose uptake was measured 
after 30 min of hormonal stimulation as described in section 2. Values 
are mean + S.D., n--3. Significance over basal indicated by * at 
P<0.05. 
Insulin stimulation increased cell surface GLUT1 by 16%, 
GLUT4 by 63% and GLUT3 by 103% above basal levels (Fig. 
2). Of these increments, only the GLUT3 was statistically dif- 
ferent from basal. There was no statistical difference between 
the cell surface quantities of GLUT1, GLUT4 and GLUT3 in 
the insulin-stimulated state. 
Relative to basal levels, IGF- I  stimulation increased cell sur- 
face GLUT1 by 46%, (which was 26% greater than the insulin- 
stimulated value), GLUT4 by 68% (only 3% greater than with 
insulin), and GLUT3 by 240% (67% greater than with insulin) 
(Fig. 2). The cell surface levels of both GLUT4 and GLUT1 
in IGF- I  treated cells were significantly different from the basal 
GLUT3 levels. The IGF-I-stimulated increase in cell surface 
GLUT3 was significantly different from both basal and insulin- 
treated GLUT3 quantities. This level of surface GLUT3 was 
also statistically different from IGF-I-stimulated surface 
GLUT I  and GLUT4, and of all three glucose transporter 
isoforms at the surface in either the basal or insulin-stimulated 
myotubes. The change in cell surface GLUT4 in response to 
IGF-I  was not statistically different from basal or insulin- 
treated GLUT4 levels. GLUT1 surface levels in response to 
IGF- I  were significantly different from the basal state but not 
significantly different from the insulin-stimulated quantities. 
3.3. Subcellular distribution of GLUT1, GLUT3, and GLUT4 
Previous studies have demonstrated the translocation of 
GLUT1, GLUT3 and GLUT4 of L6 cells in response to either 
insulin or IGF-I. Therefore, plasma membrane-enriched and 
light microsome-enriched fractions were prepared from cells 
and Western blotted to confirm that comparable translocation 
occurred in the present series of experiments. 
Insulin stimulation resulted in a 20% increase in GLUT1, a 
28% increase in GLUT4, and a 42% increase in GLUT3 in the 
plasma membrane fraction (Table 1). Concomitant losses of 
each transporter were observed in the light microsome fraction 
(GLUT1 decreasing by 44%, GLUT4 by 27%, and GLUT3 by 
44%). These results were comparable to the insulin-stimulated 
translocation shown previously [1,2,6]. IGF-I  treatment, in- 
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Fig. 2. Cell surface content of GLUTI, GLUT4 and GLUT3 in basal, 
insulin and IGF-Itreated L6 myotubes. Using ATB-BMPA, cell surface 
levels of each glucose transporter isoform for each treatment was deter- 
mined and corrected to pmol/mg total protein as described insection 
2. Values are mean + S.E.M. (n = 5-7). Significance was accepted atthe 
P< 0.05 level where: * indicates significance ompared to all isoforms 
under all treatments; m indicates ignificance compared to basal 
GLUT1; ÷ indicates significance ompared to basal GLUT3. 
creased plasma membrane levels of GLUT4 by 34% and 
GLUT3 by 43%, similar to insulin-treatment (Table 1). IGF-I 
treatment also caused losses from the light microsome mem- 
branes of GLUT1, GLUT4 and GLUT3 (24%, 16%, and 63%, 
respectively). With the exception of the apparent lack of IGF-I 
induced changes in plasma membrane GLUT1 in this study, 
most likely due to a technical difficulty in recovering the frac- 
tion, the results here are comparable to the translocation i
response to IGF-I shown previously [1,2,6]. 
Thus, as determined by membrane fractionation, insulin and 
IGF-I stimulated a similar movement from the light microsome 
fraction to the plasma membrane fraction of each isoform. By 
photolabeling, allthree glucose transporter isoforms were pres- 
ent in similar quantities at the cell surface in basal L6 cells. 
Insulin and IGF-I treatments resulted in comparable increase 
of GLUT1 and GLUT4 at the cell surface. However, IGF-I 
treatment increased cell surface GLUT3 to a greater extent 
than did insulin, and this appeared to exceed the net increase 
as determined by membrane fractionation. 
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4. D iscuss ion  
The impermeant exofacial photolabel ATB-BMPA binds to 
glucose transporters and appears to label the active cell surface 
glucose transporters, or those capable of transporting glucose, 
and thus is a valuable approach to studying the contributions 
of individual glucose transporter isoforms to glucose uptake in 
cells expressing multiple isoforms. The L6 myotubes have been 
shown to express multiple glucose transporter isoforms and 
respond to hormonal stimulation by increasing glucose uptake. 
Insulin stimulation of L6 cells caused the translocation f all 
three glucose transporter isoforms, measured as a decrease in 
the light microsome content and an increase in the plasma 
membrane content, as shown previously [1,2,6]. Measurement 
of the photoaffinity labeled glucose transporters showed that 
there were similar amounts of each transporter at the surface 
of L6 cells in the basal state and that, although the increment 
over basal evels for each isoform differed, similar molar quan- 
tities of GLUT1, GLUT3 and GLUT4 were found at the cell 
surface of insulin-stimulated cells. 
The most striking result was the effect of IGF-I treatment on 
GLUT3 photolabeling. The IGF-I-stimulated 2-deoxyglucose 
uptake was 3. l-fold greater than basal and 30% greater than 
insulin-stimulated uptake. The apparent translocation of all 
three isoforms in response to IGF-I was similar to that seen 
following insulin-stimulation as described previously [1,2,6]. 
The increase in cell surface ATB-BMPA labeled GLUT1 and 
GLUT4 in IGF-I treated cells was similiar to that with insulin- 
stimulation. However, cell surface ATB-BMPA labeled 
GLUT3 content was greater in IGF-I treated than insulin- 
treated cells. This indicates that IGF-I stimulation of L6 cells 
causes a translocation f GLUT1, GLUT4, and GLUT3 simi- 
lar to that seen with insulin, with a further increase in the 
accessibility of cell surface GLUT3 to ATB-BMPA. 
Using the same methods employed here, the presence of both 
active and inactive transporters in adipocyte plasma mem- 
branes was proposed previously. Glucose transport activity 
correlated most closely with the amount of GLUT4 photola- 
beled with ATB-BMPA at the cell surface rather than with the 
total number of GLUT4 transporters present in the plasma 
membrane fraction as determined by Western blotting [19,20]. 
Thus, transporters may be present at or in the plasma mem- 
brane in an active state, accessible to glucose or the photolabel, 
Table 1 
Glucose transporters inmembrane fractions (relative units/mg protein) 
Plasma membranes Light microsomes 
Basal Insulin IGF-I Basal Insulin IGF-I 
GLUT 1 
Relative to basal PM 1.00 1.20 1.03 0.38 0.21 0.29 
S.D. 0.08 0.18 0.08 0.07 0.03 0.08 
GLUT 4 
Relative to basal PM 1.00 1.28 1.34 0.51 0.37 0.43 
S.D. 0.17 0.21 0.23 0.09 0.16 0.12 
GLUT 3 
Relative to basal PM 1.00 1.42 1.43 0.47 0.19 0.17 
S.D. 0.11 0.33 0.33 0.05 0.08 0.09 
The distribution of each transporter isoform in plasma membrane and light microsomal membrane fractions made from basal and hormone-stimulated 
cells is shown. The values are given relative as densitometric units/mg protein (mean + S.D., n = 3), where the basal plasma membrane fraction value 
for each isoform was set equal to 1.00. 
22 C.M. Wilson et al./FEBS Letters 368 (1995) 19-22 
and an inactive state (or occluded) which was inaccessible to 
ATB-BMPA. If this is also the case for GLUT3 then the addi- 
tional cell surface GLUT3 in IGF-I  treated cells, which exceed 
the relative movement to the plasma membrane fraction, would 
suggest that IGF-I  somehow increases (or 'activates') the num- 
ber of cell surface accessible GLUT3 glucose transporters in the 
plasma membrane. This might account for the higher glucose 
transport activity in the presence of IGF-I  as compared to 
insulin. 
To correlate glucose transporter number with glucose trans- 
porter activity, when more than one glucose transporter 
isoform is present, the following parameters need to be consid- 
ered: (1) the relative abundance and accessibility to glucose of 
each isoform on the cell surface; (2) the affinity of each isoform 
for the substrate at the concentrations u ed to measure trans- 
port; and (3) the turnover number for each isoform. The rela- 
tive abundance of GLUT1, GLUT3 and GLUT4 at the cell 
surface of L6 myotubes has been presented in this report. Cur- 
rent data suggests that GLUT1 has a low affinity (K m 10-20 
raM), while GLUT 4 and GLUT3 have higher affinities 
(GLUT4, 1.8 7 mM and GLUT3, 3-10 mM) [4,17,21]. Assum- 
ing that the turnover number and Vmax for all three isoforms 
are similar, and the Km is as listed above, then our data suggests 
that GLUT3 and GLUT4 account for glucose uptake in basal 
and insulin-stimulated cells, while GLUT3 probably accounts 
for the further elevation in glucose uptake with IGF-I  treat- 
ment. 
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